D. Uddin, I. Zerin, S. Habib, A. Hosen, and J. Khatun, “Chemotherapy in combination with Trastuzumab is better than chemotherapy alone in HER2 positive breast cancer patients”, BMCJ, vol. 2, no. 2, pp. 15–20, Dec. 2016, doi: 10.70818/bmcj.2016.v02.i1.063.